Search results

A Monosaccharide Residue Is Sufficient to Maintain Mouse and Human IgG Subclass Activity and Directs IgG Effector Functions to Cellular Fc Receptors.

Immunoglobulin G (IgG) glycosylation modulates antibody activity and represents a major source of heterogeneity within antibody preparations. Depending on their glycosylation pattern, individual IgG glycovariants present in recombinant antibody preparations may trigger effects ranging from enhanced pro-inflammatory activity to increased anti-inflammatory activity. In contrast, reduction of IgG gly

A role for PKC-epsilon in Fc gamma R-mediated phagocytosis by RAW 264.7 cells

Protein kinase C (PKC) plays a prominent role in immune signaling, and the paradigms for isoform selective signaling are beginning to be elucidated. Real-time microscopy was combined with molecular and biochemical approaches to demonstrate a role for PKC-epsilon in Fcgamma receptor (FcgammaR)-dependent phagocytosis. RAW 264.7 macrophages were transfected with GFP-conjugated PKC isoforms, and GFP m

Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-Associated hemolysis

Functional Variants of Fc Gamma Receptor (FCGR2A) and FCGR3A Are Not Associated with Susceptibility to Systemic Sclerosis in a Large European Study (EUSTAR).

OBJECTIVE: To investigate the possible role of FCGR2A 519A>G and FCGR3A 559A>C functional polymorphisms in the genetic predisposition to susceptibility to systemic sclerosis (SSc) or clinical phenotype. METHODS: A total of 1566 patients with SSc and 2271 geographically matched controls were included in our study. We analyzed the genotype and allele frequencies of the FCGR2A 519A>G and FCGR3A 559A>

Real-world prophylactic usage of recombinant factor IX Fc in Sweden : A report from the Swedish National Registry for bleeding disorders

Real-world prophylactic usage of recombinant factor VIII Fc in Sweden : A report from the Swedish national registry for bleeding disorders

Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering

Recombinant factor IX Fc for the treatment of hemophilia B

Current hemophilia B treatment guidelines recommend routine prophylaxis with factor IX (FIX) replacement products, tailored to maintain plasma activity at levels that will prevent bleeds. However, plasma FIX activity may not be the primary determinant or best indicator of hemostatic efficacy due to its extravascular distribution. FIX replacement therapy has evolved to include extended half-life (E

Polymorphisms of the Fc gamma receptor type IIB gene are not associated with systemic lupus erythematosus in the Swedish population

Företagsekonomi: Strategisk ekonomistyrning

Strategisk kommunikation: Kriskommunikation i organisationer och samhällen

Bioteknologi inom försvar och säkerhet: medicinska möjligheter och juridiska utmaningar

Management: Understanding Management

Miljö- och hållbarhetsvetenskap: Metoder och verktyg - från kunskap till handling

Politik och samhälle i det samtida Mellanöstern - Masterprogram

FONM26 SLUTLIG

https://www.sol.lu.se/media/utbildning/dokument/kurser/FONM26/20212/FONM26_SLUTLIG.pdf - 2026-04-20

Redovisning och finansiering, Accounting and Management Control - Magisterprogram

LL SMMV26 eng VT26 rev 260123

https://www.ses.lu.se/en/sites/ses.lu.se.en/files/2026-01/LL_SMMV26_eng_VT26_rev_260123.pdf - 2026-04-21

Ll smmr26

https://www.ses.lu.se/en/sites/ses.lu.se.en/files/ll_smmr26.pdf - 2026-04-21